文献速递类风湿关节炎脊柱关节炎

炎症性关节炎治疗机会缺失及与未治疗相关因素:美国退伍军人类风湿关节炎、银屑病关节炎或强直性脊柱炎观察性队列研究

Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
PubMed 文献 · Semin Arthritis Rheum · 2024-03-28

该观察性队列研究纳入2007至2019年诊断为炎症性关节炎的退伍军人共18318例,40.7%在诊断后12个月内未接受生物或非生物改善病情抗风湿药治疗,黑人种族、西班牙裔、Charlson合并症指数≥2及阿片类药物使用与未治疗相关,而风湿科医生诊断、女性诊断医生、医患性别一致及影像学侵蚀与更高的治疗频率相关。

要点

  • 在18318例炎症性关节炎退伍军人中,40.7%在诊断后12个月内未接受生物或非生物改善病情抗风湿药治疗。
  • 黑人种族、西班牙裔、Charlson合并症指数≥2及阿片类药物使用与未治疗风险升高相关。
  • 由风湿科医生诊断、女性诊断医生、医患性别一致及影像学报告显示侵蚀与更高的治疗频率相关。

核心结论

  • 高比例的炎症性关节炎退伍军人在初次诊断后一年内未接受生物或非生物改善病情抗风湿药治疗。
  • 多种因素与炎症性关节炎未治疗相关,可能代表通过早期启动改善病情抗风湿药来改善医疗质量的机会缺失。

研究设计与样本

  • 观察性队列研究,纳入2007至2019年诊断为炎症性关节炎的美国退伍军人共18318例。
  • 采用Kaplan-Meier曲线评估至治疗时间,采用多变量广义估计方程(GEE)对数泊松模型分析未治疗与患者、提供者及卫生系统因素的相关性。
  • 亚组分析包括炎症性关节炎亚型(类风湿关节炎、银屑病关节炎和强直性脊柱炎)及初始诊断时间段(2007-11、2012-15和2016-19)。

主要发现

  • 在18318例研究患者中,40.7%在诊断后12个月内未接受治疗。
  • 在所有患者中,与未治疗相关的因素包括黑人种族(风险比1.13,95%置信区间1.08-1.19)、西班牙裔(1.14,1.07-1.22)、Charlson合并症指数≥2(1.15,1.11-1.20)及阿片类药物使用(1.09,1.05-1.13)。
  • 与更高频率的改善病情抗风湿药治疗相关的因素包括已婚状态(0.86,0.81-0.91)、关节影像报告显示侵蚀(风险比0.86,0.81-0.91)、女性诊断提供者(0.90,置信区间0.85-0.96)、患者与提供者性别一致(0.91,置信区间0.86-0.97)及诊断提供者专科为风湿科(0.53,置信区间0.49-0.56)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify factors associated with non-treatment with biologic and non-biologic disease modifying anti-rheumatic drugs (DMARDs) during the 12 months after initial inflammatory arthritis (IA) diagnosis. METHODS: We identified Veterans with incident IA diagnosed in 2007-2019. We assessed time to treatment with Kaplan-Meier curves. We identified associations between non-treatment and factors relating to patients, providers, and the health system with multivariate Generalized Estimation Equation (GEE) log-Poisson. Subgroup analyses included IA subtypes (rheumatoid arthritis [RA], psoriatic arthritis [PsA], and ankylosing spondylitis [AS]) and timeframes of the initial IA diagnosis (2007-11, 2012-15, and 2016-19). RESULTS: Of 18,318 study patients, 40.7 % did not receive treatment within 12 months after diagnosis. In all patients, factors associated with non-treatment included Black race (hazard ratio, 95 % confidence interval: 1.13, 1.08-1.19), Hispanic ethnicity (1.14, 1.07-1.22), Charlson Comorbidity Index ≥2, (1.15, 1.11-1.20), and opiate use (1.09, 1.05-1.13). Factors associated with higher frequency of DMARD treatment included married status (0.86, 0.81-0.91); erosion in joint imaging report (HR: 0.86, 0.81-0.91); female diagnosing provider (0.90, CI: 0.85-0.96), gender concordance between patient and provider (0.91, CI: 0.86-0.97), and diagnosing provider specialty of rheumatology (0.53, CI: 0.49-0.56). CONCLUSION: A high proportion of Veterans with IA were not treated with a biologic or non-biologic DMARD within one year after their initial diagnosis. A wide range of factors were associated with non-treatment of IA that may represent missed opportunities for improving the quality of care through early initiation of DMARDs.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Walsh JA, Pei S, Alexander S, et al. Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Semin Arthritis Rheum. 2024. PMID: 38714073. doi:10.1016/j.semarthrit.2024.152436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。